Fimbrioscopy and salpingoscopy in patients with minimal to moderate pelvic endometriosis

Obstetrics and gynecology · 1990 · vol. 75(1) , pp. 15–7 · PMID:2296415 · W2399709612
Observational OA: closed CC0 ⤵ 16 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

Fimbrioscopy and salpingoscopy in 100 endometriosis patients and 20 controls found perifimbrial adhesions in five patients but no endosalpinx adhesion formation, indicating no link between endometriosis and intratubal disease.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Fimbrioscopy and salpingoscopy were performed with a rigid salpingoscope during operative laparoscopy in 100 patients with minimal to moderate endometriosis and in 20 normal controls. Five women with endometriosis had perifimbrial adhesions, compared with none of the controls. No subject in either group had adhesion formation of the endosalpinx. These observations indicate that there is no association between endometriosis and intratubal disease.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endoscopy Endoscopy Fallopian Tubes Pelvic Neoplasms Endometriosis Endometriosis Fallopian Tubes Fallopian Tubes Female Female Humans Humans Pelvic Neoplasms Pelvic Neoplasms Tissue Adhesions Tissue Adhesions Tissue Adhesions

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (12)

Source provenance

europepmc
last seen: 2026-10-10T06:11:15.153948+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:10:46.340120+00:00
License: CC0 · commercial use OK